id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-310868-rqmny4r2	Tesfaye, Wubshet	How Do We Combat Bogus Medicines in the Age of the COVID-19 Pandemic?	2020-08-18		.txt	text/plain	2862	157	39	15 For the Global South, the pandemic exacerbates the existing proliferation of substandard and falsified medical products, and these trends are likely to continue as effective drugs continue to emerge from ongoing trials. The WHO defines substandard products as "authorized medical products that fail to meet quality standards or specifications, or both" and falsified products as "products that deliberately/ fraudulently misrepresent identity, composition, or source." 16 Considering less than 30% of regulatory agencies in the world can ensure the adequacy of medicines and vaccines, 17 pandemics of COVID-19 proportion would inevitably present enormous regulatory challenges. There is a risk that when the COVID-19 pandemic further spreads in LMICs, there will be an increased potential for the distribution of falsified and counterfeit medicines, something the international community needs to be alert to and work against. In meeting these needs, governments, pharmaceutical regulatory agencies, and associate supply chains must have practical and financially supported strategies to ensure quality-assured medicines are made available for the determined need.	./cache/cord-310868-rqmny4r2.txt	./txt/cord-310868-rqmny4r2.txt